World-class Expertise, Collaboration and Caring in the Treatment of Neuroendocrine Tumors

At the Neuroendocrine Program at Presbyterian/St. Luke's in Denver, Colorado, our unmatched expertise and commitment to personalized care draws patients from around the country.

Our NET team works closely with each patient to craft a comprehensive treatment plan, which can include:

  • Surgery — Surgery is the preferred treatment for many neuroendocrine tumors, often even when the tumor has spread to other locations in the body. Dr. Liu is experienced at determining the best surgical approach for each type, size, and location of tumor, and has perfected minimally invasive surgical techniques, which speed patient recovery.
  • Hormone Therapy— For many NETs patients, ongoing therapy with agents that block the release of hormones can be effective in slowing or halting tumor growth.
  • Chemotherapy— Traditional chemotherapy can sometimes play a role in the treatment of neuroendocrine tumors, particularly when those tumors are especially aggressive.
  • Interventional Radiology— Interventional radiology continues to play an increasingly important role in the treatment of NETs patients where the disease has resulted in liver metastases.
  • Clinical Trials— These studies represent the latest advancements in therapeutic treatments.

Presbyterian/St. Luke's is the only hospital in the Rocky Mountain region, and one of only a handful in the country, to offer the Gallium 68 dotatate PET scan in the treatment of NETs.

This radioactive diagnostic agent allows surgeons to pinpoint the precise location of tumors before beginning surgery-- a critical step in effective treatment.